ArticleApplied microbiology and biotechnology2026
Enzyme-constrained genome-scale model of Yarrowia lipolytica predicts growth-phase specific metabolic engineering targets.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The oleaginous yeast Yarrowia lipolytica has been gaining increasing importance as an industrial biotech platform, supported by several available metabolic engineering tools. Genome-scale models (GEMs) are relevant to the iterative improvement of this yeast, and their predictive ability is enhanced by enzymatic activity constraints (ecGEMs). Although the newest tools for ecGEM reconstruction use deep learning to expand the coverage of these constraints, this approach has not yet been applied to Y. lipolytica models. This paper describes the reconstruction of an ecGEM of Y. lipolytica (eciYali5-GEM) and its application in predicting metabolic engineering targets for enhanced lipid and carotenoid production, respectively, in this yeast. To achieve this, we constrained a manually curated Y. lipolytica model with physiological flux and mass-spectrometry proteomics data collected from distinct growth phases of two engineered strains (producing lipids and carotenoids, respectively) and their parental strain. We found that the enzymatic constraints enable the prediction of growth-phase-specific metabolic engineering targets, a feature not displayed by regular GEMs. Combining these targets with other ecGEM-based insights, we propose two strategies for further metabolic engineering, including the use of inducible promoters for precise, growth-phase-specific expression of targets such as phytoene dehydrogenase for carotenoid production. These targets included genes previously validated elsewhere, as well as novel genes awaiting experimental validation. This model, which is publicly available, can be similarly adapted and used by different metabolic engineering efforts, making it a versatile tool for the development of Y. lipolytica as a microbial cell factory. KEY POINTS: • eciYali5-GEM reconstruction used in silico and in vitro proteomics data. • Enzyme constraints enriched Y. lipolytica ecGEM predictions. • eciYali5-GEM improves metabolic engineering rational design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.